Alessandro Moretta
Alessandro Moretta
School of Medicine, University of Genova, Italy
Email verificata su
Citata da
Citata da
Innate or adaptive immunity? The example of natural killer cells
E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ...
science 331 (6013), 44-49, 2011
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ...
The Journal of experimental medicine 190 (10), 1505-1516, 1999
Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms
ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ...
Cancer research 67 (19), 9142-9149, 2007
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis
M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ...
The Journal of experimental medicine 187 (12), 2065-2072, 1998
Natural killer cells and dendritic cells: rendezvous in abused tissues
A Moretta
Nature Reviews Immunology 2 (12), 957-965, 2002
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ...
Immunity 6 (2), 199-208, 1997
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a …
R Maccario, M Podestà, A Moretta, A Cometa, P Comoli, D Montagna, ...
Haematologica 90 (4), 516-525, 2005
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
L Moretta, A Moretta
The EMBO journal 23 (2), 255-259, 2004
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains
N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ...
Immunity 2 (5), 439-449, 1995
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
CS Brandt, M Baratin, EC Yi, J Kennedy, Z Gao, B Fox, B Haldeman, ...
Journal of Experimental Medicine 206 (7), 1495-1503, 2009
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
A Pessino, S Sivori, C Bottino, A Malaspina, L Morelli, L Moretta, ...
The Journal of experimental medicine 188 (5), 953-960, 1998
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
G Ferlazzo, D Thomas, SL Lin, K Goodman, B Morandi, WA Muller, ...
The Journal of Immunology 172 (3), 1455-1462, 2004
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to …
D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ...
Cancer research 62 (21), 6178-6186, 2002
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells
R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ...
Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003
p46, a novel natural killer cell–specific surface molecule that mediates cell activation
S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 186 (7), 1129-1136, 1997
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of …
A Moretta, M Vitale, C Bottino, AM Orengo, L Morelli, R Augugliaro, ...
The Journal of experimental medicine 178 (2), 597-604, 1993
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20